A Haegert

Latest

• Multiomics Characterization of Low-grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK-inhibitor Sensitivity and Therapeutic Vulnerability
• Well-Differentiated Papillary Mesothelioma of the Peritoneum is Genetically Distinct from Malignant Mesothelioma
• BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma
• BIRC6-targeting as potential therapy for advanced, enzalutamide-resistant prostate cancer
• Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer